Author: Touma, Marlin
Title: COVID-19: molecular diagnostics overview Cord-id: bn4i60gi Document date: 2020_6_13
ID: bn4i60gi
Snippet: The last day of 2019 delivered the first report to the World Health Organization (WHO) about a group of cases of pneumonia of unknown etiology in Wuhan, China. Subsequent investigations identified the new comer, a novel coronavirus related to severe acute respiratory syndrome coronavirus (SARS-CoV) and thus was termed as SARS-CoV-2. Being very contagious, the new virus led the era of “COVID-19†which is the acronym of “coronavirus disease 2019,†evoking an imminent threat to global healt
Document: The last day of 2019 delivered the first report to the World Health Organization (WHO) about a group of cases of pneumonia of unknown etiology in Wuhan, China. Subsequent investigations identified the new comer, a novel coronavirus related to severe acute respiratory syndrome coronavirus (SARS-CoV) and thus was termed as SARS-CoV-2. Being very contagious, the new virus led the era of “COVID-19†which is the acronym of “coronavirus disease 2019,†evoking an imminent threat to global health security with unprecedented devastating challenges to human kind. In this article, we provide a molecular overview on the SARS-CoV-2 virus and summarize tremendous efforts that have been made to develop a rapid confirmatory diagnostic test for COVID-19. The diagnostic performances of the available tests are analyzed based on the best current information from the early research.
Search related documents:
Co phrase search for related documents- absolute lymphocyte count and active disease: 1
- acid testing and active disease: 1
- acid testing and acute diagnostic: 1, 2
- acid testing and liver transaminase: 1
- active disease and acute diagnostic: 1
- active disease and additional measure: 1
- active disease and liver transaminase: 1
Co phrase search for related documents, hyperlinks ordered by date